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Sustained Symptomatic Sinus Node Reentrant Tachycardia: Incidence,
Clinical Significance, Electrophysiologic Observations and the Effects
of Antiarrhythmic Agents
JOSEPH A. GOMES, MD, FACC,* ROBERT J. HARIMAN, MD, FACC,
PRITPAL S. KANG, MD, FACC, IMTIAZ H. CHOWDRY, MD
Brooklyn. New York
The clinical, electrocardiographic and electrophysiologic
determinants and effects of antiarrhythmic agents on
sustained sinus node reentrant tachycardia remain poorly
defined. Of 65 consecutive men undergoing electro-
physiologic studies for symptomatic paroxysmal supra-
ventricular tachycardia over a 4 year period, 11 (16.9%),
who ranged in age from 39 to 76 years, demonstrated
sustained sinus node reentrant tachycardia. On the sur-
face electrocardiogram, before electrophysiologic stud-
ies, the following diagnoses were considered i~ the 11
patients: 1)sinus node reentrant tachycardia on the basis
of an RP' /P'R ratio of greater than 1 and P wave con-
figuration similar to that of sinus P waves (7 patients);
2) atrioventricular (AV) nodal reentrant tachycardia on
the basis of an RP' /P'R ratio of less than 1 (3 patients);
and 3) paroxysmal atrial tachycardia with AV block (1
patient). All 11 patients had a history of recurrent pal-
pitation, 4 had syncope, 2 had dizzy spells and 9 had
organic heart disease.
Sustained sinus node reentrant tachycardia could be
reproducibly induced in all 11patients during atrial pac-
ing or premature atrial stimulation, or both, over a wide
echo zone. The tachycardia could be terminated by ca-
rotid sinus massage, atrial pacing and premature atrial
stimulation. Characteristics of tachycardia included: 1)
high-low activation sequence; 2) cycle lengths of 250 to
In 1972, Narula (1) reported that induced atrial premature
beats may be followed by atrial complexes that have the
same configuration and activation sequence as those of nor-
mal sinus beats. Narula (2) also postulated reentry within
the sinus node as the mechanism of these atrial complexes
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590 ms with wide fluctuations of 20 to 180 ms in indi-
vidual patients; 3) RP' /P'R ratio of greater than 1 in 8
(73%) of the 11 patients and a ratio or less than 1 in 3
(27%). Induction of sustained sinus node reentrant
tachycardia was prevented by intravenous ouabain (0.01
mg/kg body weight) in two of two patients, by intrave-
nous verapamil (10 mg) in two of two patients and by
intravenous amiodarone (5 mg/kg body weight) in four
of four patients. In contrast, intravenous propranolol
(0.1 mg/kg body weight) did not affect induction of sus-
tained sinus node reentrant tachycardia in two of two
patients.
It is concluded that 1) sustained sinus node reentrant
tachycardia, seen in 16.9% of the study patients with
paroxysmal supraventricular tachycardia, is not as be-
nign as previously believed; 2) it is frequently associated
with organic heart disease; 3) it demonstrates wide vari-
ations in cycle length, unlike other forms of paroxysmal
supraventricular tachycardia; 4) it can masquerade as
AV nodal reentrant tachycardia and paroxysmal atrial
tachycardia with AV block on the surface electrocar-
diogram in 36% of patients; and 5) it is responsive to
intravenous administration of ouabain, verapamil or
amiodarone.
(J Am Coll CardioI1985;5:45-57)
and formulated criteria for diagnosis of sinus node reentry
in human patients. Subsequently, several investigators (3-11)
reported on the phenomenon of sinus node echo beats and
clinical cases of atrial tachycardia that satisfied the criteria
for sinus node reentry. However, to date there have been
fewer than 35 reported cases of sustained sinus node reen-
trant tachycardia, Despite these reports, the incidence, clin-
ical significance, electrophysiologic determinants and ef-
fects of antiarrhythmic agents on sustained sinus node reentrant
tachycardia remain poorly defined. Of 65 consecutive men
with symptomatic paroxysmal tachycardia studied in our
laboratory over a 4 year period, II (16.9%) demonstrated
0735-1097/85/$3.30
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electrophysiologic evidence of sustained sinus node reen-
trant tachycardia. The purpose of this paper is to discuss I)
the clinical. electrocardiographic and electrophysiologic ob-
servations in patients with sustained sinus node reentrant
tachycardia, and 2) the effects of various antiarrhythmic
agents on sustained sinus node reentrant tachycardia.
Methods
Study patients. Electrophysiologic studies were per-
formed in 65 men with paroxysmal supraventricular tachy-
cardia in the postabsorptive nonsedated state after explaining
the nature of the procedure and obtaining an informed signed
consent. All cardioactive medications were withheld for at
least 4 days before the study. None of the patients had acute
myocardial infarction or ischemia and none had electrolyte
or metabolic disturbances.
Electrophysiologic studies. With the use of the per-
cutaneous Seldinger technique, three quadripolar catheters
(USCI, no. 6) with IO mm interelectrode distance were
introduced percutaneously through femoral veins and po-
sitioned in the high right atrium. at the level of the tricuspid
valve for recording His bundle activity and in the right
ventricular apex . When necessary, one of the catheters was
positioned in the mid right atrium, the low right atrium or
coronary sinus to determine atrial activation sequence. The
proximal poles of the catheters in the high right atrium and
right ventricular apex were utilized for recording electro-
grams; the distal poles were used for stimulation. However.
when sinus node reentry was induced . the distal pole of the
catheter positioned vertically in the high right atrium (through
the femoral vein) was utilized for recording the electrogram
from the region of the sinus node and the distal pole of the
second catheter was utilized for pacing the region of the
high right atrium.
All patients underwent complete anterograde and ret-
rograde conduction studies that included: I) atrial pacing
up to cycle lengths between 300 and 280 ms; 2) programmed
Table I. Clinical Features of I I Patients
atrial stimulation (S,S2 and S,S2S3) at one or more cycle
lengths; 3) incremental ventricular pacing up to cycle lengths
of 250 ms; and 4) programmed premature ventricular stim-
ulation at one or more cycle lengths . Atrial and ventricular
stimulation studies were performed at twice diastolic thresh-
old with stimuli 2 ms in duration . Two to three electrocar-
diographic leads (usually I. II and VI), intracardiac elec -
trograms at filter frequencies of 30 to 500 Hz and time lines
generated at 40,200 and 1,000 ms were displayed on a
multichannel oscilloscope (Varian Associates. VR-12 mul-
tichannel recorder) and recorded on thermal paper at paper
speeds of 50 to 100 mm/s ,
Definition of terms. Sinus node reentrant tachycardia
was defined if it satisfied the following criteria (2.6). I) The
sequence of atrial activation was from high right atrium to
low right atrium in the region of the atrioventricular (AV)
junction and similar to that of sinus beats; 2) the polarity
and configuration of the P waves were similar to if not
identical to the configuration of sinus P waves ; 3) the tachy-
cardia could be induced over a zone of S.SI (that is. atrial
pacing cycle length) . S,S2 or S2S3 intervals; 4) the tachy -
cardia could be terminated by appropriately timed atrial
premature stimuli; 5) the induction of tachycardia or echo
beats, or both, was independent of AV nodal conduction
delays.
Sustained sinus node reentrant tachycardia. The tachy-
cardia was considered to be sustained if it persisted for at
least I minute. Patients in whom only sinus echo beats were
induced are not the subject of this report.
Echo zone. This was defined as the range of coupling
intervals (S IS2 or S2S3) that induced sinus node echo beats
or sustained node reentrant tachycardia, or both.
Statistical analysis was performed by utilizing the Stu-
dent's t test. All values represent the mean ± standard
deviation .
Drug studies. In 8 of II patients in whom sustained
sinus node reentrant tachycardia was induced. a total of 10
Age
Case (yr) Symptoms Diagnosis
I 47 Palpitation ASHD
2 77 Palpitation, syncope ASHD, hypertension
3 60 Syncope None
4 56 Palpitation ASHD
5 55 Palpitation. dizzy spells ASHD
6 61 Palpitation. dizzy spells None
7 59 Palpitation HCVD
8 76 Palpitation ASHD
9 39 Palpitation ASHD
10 54 Palpitation. syncope/dizzy ASHD
spells
II 67 Palpitation, syncope ASHD
ASHD = atherosclerotic heart disease; HCVD = hypertensive cardiovascular disease.
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Figure 1. Patient 7. Standard 12 lead electrocardiogram during
supraventricular tachycardia. P waves are not clearly discernible.
as in AV nodal tachycardia. The triangle points to the questionable
P wave in the rhythm strip (lead II). See text.
drug studies were performed after the administration of the
following drugs: I) intravenous propranolol, 0.1 mglkg body
weight (2 patients); 2) intravenous ouabain, 0.01 mg/kg
body weight (2 patients); 3) intravenous verapamil, 10 mg
(2 patients); and 4) intravenous amiodarone, 5 mg/kg body
weight as a slow continuous infusion over 20 minutes (4
patients).
Results
Clinical Observations
Of the 65 patients with symptomatic paroxysmal supra-
ventricular tachycardia, AV nodal reentrant tachycardia was
induced in 38 (58%), reentrant supraventricular tachycardia
associated with the Wolff-Parkinson-White syndrome in 8
patients (12%), reentrant supraventrical tachycardia utiliz-
ing a concealed bypass tract in 7 patients (II %), intraatrial
reentry in 1 patient (1.5%) and sustained sinus node reen-
trant tachycardia in 11 patients (17%).
Clinical features (Table 1). The 11 patients were all
male and ranged in age from 39 to 76 years (mean 60 ±
11). All 11 patients had a history of recurrent palpitation
and 6 (55%) had dizzy spells or syncope, or both. Nine of
the 11 patients (82%) had atherosclerotic heart disease or
hypertensive heart disease, or both; 7 (64%) had a prior
myocardial infarction of whom 5 had prior inferior wall
infarction. The site of infarction could not be determined
in one patient who had left bundle branch block. All II
Figure 2. Patient 8. Standard 12 lead electrocardiogram during
supraventricular tachycardia. P waves are not clearly discernible,
as inAVnodal reentrant tachycardia. Carotid sinusmassage (C.S.M.)
results in termination of the tachycardia.
patients had spontaneous supraventricular tachycardia dem-
onstrated on a 12 lead electrocardiogram or 24 hour am-
bulatory Holter recording. None of the patients had sick
sinus syndrome.
Electrocardiographic diagnosis. On the basis of the
surface electrocardiogram or Holter recording, seven pa-
tients (65%) were diagnosed as having sinus node reentrant
tachycardia, three (27%) as having AV nodal reentrant
tachycardia and one (9%) as having atrial tachycardia with
AV block (serum digoxin level 0.5 ng/ml). Electrocardio-
grams from Patients 7 and 8 during one of the episodes of
spontaneous tachycardia are shown in Figures I and 2, re-
spectively. In both tracings during tachycardia, the P waves
were not clearly discernible. It was argued by some ob-
servers that there were P waves after the QRS complex (Fig.
I, bottom strip). but the polarity and shape of the P waves
were not clearly evident. Thus. the diagnosis of AV nodal
reentrant tachycardia was entertained in these patients.
Electrophysiologic Observations
Induction of tachycardia (Table 2). Sustained sinus
node reentrant tachycardia could be induced in all 11 patients
during atrial pacing or premature atrial stimulation. or both,
over a wide echo zone that ranged from 20 to 280 ms (mean
63 ± 78). The cycle length of tachycardia ranged from 250
to 590 ms in individual patients and approximated the ob-
served rate of tachycardia as recorded on the surface elec-
trocardiogram or 24 hour ambulatory Holter recording. Dur-
ing induced tachycardia, there was a marked variation in
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Table 2. Electrophysiologic Data From II Patients
Induction*
Echo Zone Cycle Length
Case AP PAS (ms) RP'/P'R (rns)
I + + 80 I 480 to 510
2 + + 20 0.6 360 to 390
3 + + 20 2.6 380 to 400
4 + + 25 1.4 500 to 550
5 + + 130 2. 1 450 to 500
6 + + 280 1.4 410 to 590
7 + + 20 0.3 340 to 480
8 + + 10 0.5 500
9 + + 10 2.14 470 to 490
10 + 20 1.1 360
II + + 80 2.0 250 to 270
*Ofsustained sinus node reentrant tachycardia. AP = atrial pacing; PAS = premature atrial stimulation;
+ = yes; - = no.
cycle length of 20 to 180 ms in individual patients. The
shortest cycle length of tachycardia was significantly lower
(that is. the rate was significantly faster ) in patients with
dizzy spells or syncope. or both . than in patients without
these symptoms (368 ± 61 versus 458 ± 60 rns, respec-
tively. p < 0.05). In eight patients, the RP' /P 'R ratio was
greater than I, whereas in 3 patients it was less than I .
Figure 3 is an example from Patient 7 showing induction
of sustained sinus node reentrant tachycardia during atrial
pacing (panel A) and premature atrial stimulation with a
cycle length of 340 to 480 ms after atrial pacing at a cycle
length of 340 ms. Panel B shows induction of sustained
sinus node reentrant tachycardia during atrial premature
stimulation at an 5 152 interval of 320 ms. During tachy-
Figure 3. Patient 7. Induction of sus-
tained sinus node reentrant tachycar-
dia. From top to bottom: electrocar-
diographic leads [ (L1), II (L2) and
VI; high right atrial (HRA) electro-
gram; His bundle electrogram (HBE)
and right ventricular electrogram
(RVE). Panel A shows induction of
sustained sinus node reentrant tachy-
cardia after atrial pacing at a cycle
length of 340 ms. Panel B shows in-
duction of sustained sinus node reen-
trant tachycardia (arrow) after atrial
premature stimulation at an S,S2 in-
terval of 320 ms. Note during tachy-
cardia: 1) a variation in cycle length,
and 2) a spontaneous and progressive
increase in Ae-H interval (panels B
and C) with the sinus echo beat (Ae)
occurring later and later in relation to
the next QRS complex simulating AV
nodal reentrant tachycardia.
H Y l. Hl M HV~ H ' H 1L'----1\ ! I'-"...JI I.-,~·h~t1L-,~;,~~~ r-~__..... "';'__,"-__ fr l~ !:-.-..:L-!~
B I I I I I I I I I I I I I I I
~~=:J\-=-,=t=JdL---_-'"'--'.JLLJ=
V1
RVE
I I
~
IA
Ll .rJ~
L2:------V
l
- ___
AF te 250 j e ~ l' 'r te A ~ Ae Ae Ae ~HRA A 50~ t 30 ~~~~S::-f-~M~HBElto~.~r' ,> ..' 'e H r'""o:o~+4;: 7 ~ f-~-1)~;-
L. \ I I Jf3 I I iI
L2 Iv. /\..,---" ~~~A----- I\., .J\... -'\....-~ A... A-
HRA__iJ 1 900 I ~,1 500 i~2 500 e 3 0 Ae Ae250~+e "'e " e 'le 1e ~e ~ 260 ~e I\e A.e
"'1' \(1 ... t· V, 5 "" ' 1 V~ t ' ." l~~~r\J·\~'------'~\-.--..J,...--
5 1 t 1;\ 1 8 1 1...1\1 H1 :/: 2 '~2 !;i2 U ) ,~ II_~ H Iii " ' Y, I A~ ' '> ~e il, 'fy' t·~ \.~'" ,\~e ~~ y"'' ' r H ! I~"" '''' ~ H ' ,~v.
HBE--n ,ljV "\~}I"'-- ~5~jI(Il~:I !II--h"""'" I~: : 'I ~ ~'I '(\ ~~I!~n ~II. ) i'f'-
I '''>V5d ~ , L t t l '~ ' I \ ~ I : '1.. .:.
I ~
~~~L+'~~-t::-----v=----1, V
-*Figure 4. Patie nt II. Sinus node reen trant tachycardia simulating atrial tachycardia with A V block .
Abbreviations and forma t as in Figure 3. Panel A shows a spontaneous tachycardia with AV block .
Note the upright P wave s in leads I and II and the high-low atr ial activation sequence (ver tica l
arrows). Note that the 2: I and 3 : I AV block during sinus node reentrant tachycardia is in the
AV node (dotted lines) . Panel B shows induct ion of the same tachycardia during programmed
premature stimulation at an 5 ,5 2 interval of 500 ms similar to the co upling interva l of the spontaneo us
first echo beat in panel A. Panel C shows the termi nation of tach ycardia by carotid sinus massage
(CSM) after lengthening of the tac hycardia cycle ,
C;;):
g I")
0>1")
~ <
-0
-0 -
",, '
V. 'J>
~~
I s:v. .
-'-
'"z
Si
§
m
;;<l
rr:
g.)
;j
>z
""Cli!;o
:t: :::
-<m
1")'"
>m
;;<l ""
g >>r
~
\0
50 GOMES ET AL.
SINUS NODE REENTRANT TACHYCARDIA
c--.:s==+~-
~
:J: -J
c ~---
I1i :J:
~
0
<D
<')
J;~ >'
J0<D<')
-J
-J
J
-j
,
W
>a:
JACC Vol. 5. No. I
January 1985:45-57
cardia, there was a spontaneous and progressive increase in
Ae-H interval (panels Band C) with the sinus echo beat
(Ae) occurring later and later in relation to the next QRS
complex until it merged in the previous QRS complex with
a change in RP'/P'R ratio to less than I, simulating AV
nodal reentrant tachycardia as occurred during a sponta-
neous episode of tachycardia (Fig. I). However, intracar-
diac recordings during induced tachycardia show a high-
low activation sequence.
Figure 4 shows an example of spontaneously occurring
tachycardia in Patient 11 which was diagnosed as atrial
tachycardia with AV block on the surface electrocardio-
gram, but which was established to be sustained sinus node
reentrant tachycardia with 2: I and 3: I AV block. Figure
4B shows induction of the corresponding tachycardia during
premature atrial stimulation which was promptly terminated
by carotid sinus massage (panel C).
In all 11 patients, sustained sinus node reentrant tachy-
cardia could be terminated by carotid sinus massage (Fig.
4C), atrial pacing (Fig. 5) and premature atrial stimulation.
None of the patients had increased vagal tone or AV nodal
refractoriness and none had intraatrial conduction delays.
Induction of other tachyarrhythmias. Other forms of
sustained tachyarrhythmias were not induced in any of the
11 patients. However, single AV nodal echo beats were
induced in two patients, single bundle branch reentrant beats
in three patients and one to three repetitive ventricular re-
sponses due to intraventricular reentry in three patients, all
in response to programmed ventricular stimulation. Sus-
tained or nonsustained AV nodal reentrant tachycardia or
ventricular tachycardia was not induced in any of the pa-
tients. Similarly, atrial flutter or atrial fibrillation, or both,
was not induced during programmed atrial stimulation.
Effects of drugs on sustained sinus node reentrant
tachycardia (Table 3). Propranolol. Intravenous pro-
pranolol was administered to two patients (Cases I and 7).
After the injection, sustained tachycardia could be induced
in both patients. In Patient I, intravenous propranolol in-
creased the echo zone, whereas in Patient 7, it did not
appreciably affect the echo zone. Intravenous propranolol
did not appreciably affect the cycle length of tachycardia in
either patient, although in Patient 7, there was a 2: I AV
block resulting in slowing of the ventricular response.
Ouabain. In these two patients (Cases I and 7), one
catheter was left in the high right atrium and studies were
repeated the following day. After control electrophysiologic
studies, intravenous ouabain (0.01 mg/kg) was administered
and stimulation studies were repeated to reinitiate the tachy-
cardia. After the injection, sustained tachycardia could no
longer be induced; at most, single echo beats were initiated.
In both patients, ouabain increased the echo zone (Ta-
ble 3).
Figure 6 is a representative example from Patient 1 dem-
onstrating induction of sustained sinus node reentrant tachy-
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Table 3. Effect of Antiarrhythmic Agents in 10 Drug Studies
Echo Zone ERP of
Case Drug Study Sust-T Echoes (ms) Atrium (rns)
I (prop) C + + HO JOO
D + + 150 260
7 2 (prop) C + + 20 290
D + + 20 280
J (ouab] C + + 60 290
D + 140 2HO
(single)
7 4 (ouab) C + + 20 :!70
D + 40 250
(single)
9 5 (verap) C + + 10 .Dd
D 0 JOO
10 6 (verap) C + + 20 260
D 0 260
4 7 (amio) C + + 25 200
D + 85 280
(2 echoes)
5 8 (amio) C + + 130 220
D 190 2JO
(2 echoes )
6 9 rarnio) C + + 280 260
D + 220 JOO
(2 echoes)
II 10 (arnio) C + + 80 260
D + 50 300
(8 echoes)
amio = amiodarone: C = control: D = drug: ERP = effective refractory period: ouab = ouabain: prop
= propranolol: Sust-T = sustained tachycardia: verap = verapamil: + = present: - = absent.
cardia during the control study (panel A), after atrial pacing
at a cycle length of 440 ms after the administration of pro-
pranolol (panel B) and after ouabain (panel C). Sustained
sinus node reentrant tachycardia could be induced after pro-
pranolol, but not after ouabain.
Verapamil . This drug was administered to two patients
(Cases 9 and 10). In both patients, the drug prevented the
induction of sustained sinus node reentrant tachycardia or
sinus echo beats, or both. Figure 7 is a representative ex-
ample from Patient 9. During control studies. sustained
sinus node reentrant tachycardia is induced during premature
atrial stimulation (S I S~S, ) at S I S~ and S~SJ intervals of 400
ms, respectively (panel A). The cycle length of tachycardia
ranged from 470 to 490 ms. After verapamil (panel B),
tachycardia could not be initiated at similar coupling interval.
Amiodarone. This drug resulted in the inability to initiate
sustained tachycardia in all four patients (Cases 4, 5, 6 and
II) , alihough in all four patients, two to eight echo beats
could be induced. In two of the four patients, the echo zone
decreased (Table 3). Figure 8 is an example from Patient
6. Panel A shows the induction of sustained sinus node
reentrant tachycardia after premature atrial stimulation at an
S,S2 interval of 580 ms, and panel 8 shows induction of
sustained sinus node reentrant tachycardia at a coupling
interval of 340 ms during control studies. Thus, during
control studies. the echo zone in this patient was 240 ms.
Note also that at a coupling interval of 340 ills (panel B),
sustained sinus node reentrant tachycardia was initiated when
A2 blocked within the AV node. Panel C shows the inability
to initiate tachycardia after intravenous amiodarone at an
5\52 interval of 340 ms, similar to the control studies (panel
B) .
Discussion
Previous reports. Since the original suggestion of Bar-
ker et al. ( 12) in 1943 of the possibility of reentry in the
sinus node, Han et al. (13) in 1968 carried out experiments
in the isolated rabbit heart to prove the concept of sinus
node reentry. Utilizing a single microelectrode technique,
these investigators attempted to follow the pathway of the
activation wave front within and around the sinus node after
induction of an atrial premature beat. They demonstrated
functional dissociation within the sinus node and strongly
suggested the occurrence of a reentrant phenomenon in the
sinus node. However. it was Allessie and Bonke (14 ). uti-
lizing multiple microelectrode recordings of sinus cells in
isolated rabbit hearts. who demonstrated that the mechanism
of the sinus echo after stimulation was reentry.
In the last several years, a large number of clinical supra-
ventricular tachycardias with a high-low atrial activation
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Figure 6. Patient I . Induction of sinus node reentrant tachycardia
during the control period and after propranolol (Inderal) and oua-
bain. Abbrevia tions and form at as in Figure 3. In panel A, the
intracardiac recordings are obtained at filter settings of 30 to 500
Hz and in panels Band C at 0. 1 to 50 Hz. In panel A, after
atrial pacing (a r rows) at a cycle length of 400 ms, sustained sinus
node reentrant tachycardia is induced at a cycle length of 480 to
500 ms. Note the high-low atrial activation sequence (dotted line) .
After propranolol (panel B), tachycardia can still be induced after
atrial pacing at a cycle length of 400 rns. Note that the cycle length
of tachycardia ranges from 480 to 540 ms and the atrial activation
sequence is from high to low. In panel C (after ouabain), tachy-
cardia can no longer be initiated. LRA = low right atrium .
sequence were attributed to reentry within the sinus node .
Despite those report s , little is known of the incidence and
clinical significance of sustained symptomatic sinus node
reentrant tachycardia in patients with paroxysmal suprave n-
tricular tachycardia. In fact, it is believed that sustained
sinus node reentrant tachycardi a is a rare entity and that it
plays an insignificant role in the genes is of paroxysmal
reentrant supraventricular tachycardia in human beings. Thus,
Wellens (10) reported an incidence rate of 1.8% in 379
patients studied by programm ed electrical stimulation.
However, his findings are not comp arable with those in our
group of patients since he includ ed a large number of pa-
tients with atrial flutter and ventri cular tachycardia. Wu et
al . ( 15) reported an incidence rate of 10% in 72 patients
with paroxysmal supraventricular tachycardia in whom the
mechanism of tachycardi a was del ineated by programmed
stimulation.
Path of sinus node reentry. Reentry within the sinus
node is the most plau sible mechanism of the spontaneous
and induced tachycardia in our II patients . As in all previous
clin ical studies of sinus node reentry, the exact site of reen-
try, whether in the sinus node itself, the perinodal zone or
the atrial tissue adjacent to the sinus node, cannot be stated
for certain because current techniques do not permit the
delineation of the components of the reentrant circuit. Fur-
thermore , atrial electrical events in the region of the sinus
node may not reflect sinus node events. Recentl y, this was
clearly demonstrated by Gomes et al. (\ 6, 17) by recording
sinus node electrograms in human patients. What may be
inferred, however , from this and previous clinical studies ,
is that the region of reentry is in the area of the sinus node.
The latter is suggested by the observation of a normal high
to low atrial activation sequence and P waves similar if not
identica l to sinus P waves . Slight variation in the configu-
ration of P waves durin g tachycardia may be related to
differe nt exit sites from within the sinus node , which may
not be the same as those during normal sinus rhythm .
Symptoms. Of significant clinical importance is our ob-
servation that sustained sinus node reentrant tachycardia is
not as rare or as benign as previously believed . Thi s is
suggested by the observation that I ) sustained sinus node
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Figure 7. Patient 9 , Induction of sinus node reentrant tachycardia during the control period and
after verapamil. Format as in Figure 4 , Panel A shows induction of sinus node reentrant tachycardi a
after prem ature atrial stimulation at an SlS 1 and S1S, interval of 400 ms (arrows), Note the high-
low atria l activation sequence . Panel B shows inability to initiate the tachy cardia after verapam il
at coupling intervals similar to those in panel A, A lAI = basic atria l drive ; A1A., = prem ature
atrial depolar ization : S , = stimulus artifac t. basic drive ; S2 and S, = premature stimuli.
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Figure 8. Patient8. Induction of sinus node reentrant tachycardia
during the control studies (panels A and B) and after amiodarone
(panel C). Format as in Figure 4. Panel A shows induction of
sinus node reentrant tachycardia with a cycle length of 580 ms.
Note the high-low atrial activation sequence. In panel B, the
tachycardia is induced when A2 blocks in the AV node at an 515 2
interval of 340 ms. In panel C, after amiodarone tachycardia
cannot be induced at an 515 2 interval of 340 ms similar to that in
panel B. AI = basic atrial drive; A2 = premature atrial depo-
larization; Ae = sinusecho beat; HRAd = distal polesof the high
right atrial recording; HRAp = proximal poles of the high right
atrial recording; 51 = stimulus artifact, basic drive; 52 = pre-
mature stimulus.
reentrant tachycardia was the mechanism of reentrant supra-
ventricular tachycardia in II (16.9%) of our 65 consecutive
male patients studied by programmed electrical stimulation,
and 2) all II patients were symptomatic with a history of
palpitation, dizzy spells or syncope. Although it is unclear
why our incidence of sustained sinus node reentrant tachy-
cardia was appreciably higher than that reported previously,
it may in part be related to the solely male group of patients
of higher age and with a high incidence of atherosclerotic
heart disease seen in our institution. Also the higher inci-
dence of dizzy spells or syncope, or both , in our group of
patient s , in contrast to that reported by previous investi-
gators. is probably related to the faster heart rates dur ing
tachycardia in 6 of the II patients and the presen ce of
organic heart disease.
Underlying heart disease. The findings in this study
also indicate that the majority of patients with sustained
sinus node reentrant tachycardia have organic heart disease
and variable tachycardia rates unlike patients with AV nodal
reentrant tachycardia and those utilizing concealed bypass
tracts in the reentrant process. These findings are in agree-
ment with the observations of previous investigators (9,10 ,15).
Of additional interest are our observations that the majority
of the patient s with previous myocardial infarction had had
inferior wall infarction. It is possible that in these patient s,
ischemia of the sinus node or atrial myocardium adjacent
to the sinus node may have provided the anatomic substrate
for sinus node reentrant tachycardia . Becau se coronary ar-
teriography was not performed in these patients , it is not
possible to speculate on the locat ion of the coronary arter y
lesions in relation to the sinus node artery.
Mechanism of tachycardia and diagnosis. The relation
of the P' wave to the QRS complex on the surface electro-
cardiogram has been utilized in the diagnosis of the mech-
anisrn of paroxysmal reentrant tachycardia . Thus, in the
majority of patients with AV nodal reentrant tachyc ardia,
the P' wave is negative in leads II , III and aVF and occurs
within the QRS complex or the early part of the ST segment.
In patients with a concealed bypas s tract, the P' wave fol-
lows the QRS complex. and in sinus node reentrant tachy-
cardia, the P' wave is upright in leads II, III and aVF and
precedes the QRS complex. The findings in this study in-
dicate that in the majority of patients with sinus node reen-
trant tachyc ardia , the P' wave precedes the QRS complex ,
resulting in an RP' /P' R ratio of greater than 1. However ,
in 27% of the patients , the P' wave occurred in the ST
segment of the QRS complex, resulting in an RP' /P 'R ratio
of less than I. The occurrence of P' waves within the QRS
complex in sinus node reentrant tachycardia can masquerade
as AV nodal reentrant tachycardia on the surface electro-
cardiogram. Furthermore, when P' waves occur in the early
part of the ST segment, it may be difficult to decipher their
exact configuration and polarity. This observation in three
of our patients was related to prolongation of AV nodal
conduction time during tachycardia. Thus, in sinus node
reentrant tachycardia , the longer the AV nodal conduction
time during tachycardia , the greater the possibility of the
P' wave occurring within the QRS complex or the ST segment.
Unlike AV nodal reentrant tachycardia and tachycardia
incorporating bypass tracts in the reentrant process, the tim-
ing of the P' wave to the QRS complex bears no relation
to the length or conduction velocity of the tachycardia cir-
cuit, but is dependent on the rate of tachycardia and AV
nodal conduction during tachycardia. It is noteworthy that
in one patient , sinus node reentrant tachycardia manifested
as atrial tachycardia with AV block masquerading digitalis
toxicity. Thus, in patients with sinus node reentrant tachy-
cardia in whom P ' waves are not clearly discernible before
the QRS complex and in whom the configuration and po-
larity of the P' waves are not clearly evident , the diagnosis
of sinus node reentrant tachycardia may not be evident on
the surface electrocardiogram , requiring intracardiac studies
for documentation of the mechanism of tachycardia.
Effects of antiarrhythmic agents. Unlike other forms
of reentrant paroxysmal supraventricular tachycardias, very
little is known of the effects of conventional and experi-
mental antiarrhythmic agent s on sustained sinus node reen-
trant tachycardia in human patients. Furth ermore , since it
is currently impos sible to delineate the pathways of reentry
within the sinus node , the mechanism of the action of an-
tiarrhythmic agent s will remain speculative at best. None-
theless, a drug will be effective in preventing induction of
sustained sinus node reentrant tachycardia if: I) it alters
refractor iness of reentrant pathways in the sinus node so as
to make nonuniform alteration of refractory periods similar
so that a premature beat is either blocked in both sinus node
pathways or is conducted through both pathways assuming
functional dissociation within the sinus node ; and 2) it results
in further slowing of conduction in one of the pathways to
the point of block .
Our findings suggest that intravenousl y administered pro-
pranolol has no appreciable effect in preventing induction
of sustained sinus node reentrant tachycardia. In contrast ,
ouabain was effecti ve in preventing its induct ion in two of
two patients. These observations are in agreement with the
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findings of Wellens (10). It is unclear from our study whether
the effects of ouabain were direct or vagally mediated. Pre-
vious studies in the canine heart by Pauley and Damato (18)
showed that digoxin did not appreciably affect sinus node
echo beats in 18 of 20 dogs; of which 10 were anesthetized
with alpha-chloralose and With extrinsic cardiac denerva-
tion, 5 were anesthetized with alpha-chloralose but without
extrinsic cardiac denervation and 5 were premedicated with
morphine and then anesthetized with alpha-chloralose with-
out cardiac denervation. The relative insensitivity of sinus
echo beats to digoxin was probably related to minimal or
absent vagatonic effect of digoxin in open chest dogs.
In our study intravenously administered verapamil pre-
vented the induction of sustained sinus node reentrant tachy-
cardia in two of two patients. These findings are in agree-
ment with the observations of Curry et al. (9). The effects
of verapamil on sinus node reentrant tachycardia are prob-
ably related to blockade of the slow inward calcium current
in sinus node cells. In contrast to these findings, Rinken-
berger et al. (19) reported that although intravenous vera-
pamil prevented the induction of AV nodal reentrant tachy-
cardia in two patients, it did not prevent induction of sinus
node reentrant tachycardia in the same two patients while
facilitating sustained sinus node reentrant tachycardia in one
of the patients. They postulated that the hemodynamic changes
during verapamil infusion would be expected to result in
withdrawal of vagal tone and an increase in adrenergic tone
which may have masked the direct effects of verapamil on
the sinus node. However, they also suggested that the inef-
ficacy of verapamil in two patients may have been related
to the lower doses used. Thus, verapamil may have resulted
in slowing of conduction, but not enough to induce block
in sinus node cells.
Arniodarone administered intravenously as a slow infu-
sion resulted in the inability to induce sustained sinus node
reentrant tachycardia in all four patients. However, in all
four patients two or more echo beats could still be induced.
To our knowledge, the effects of intravenous amiodarone
on sustained sinus node reentrant tachycardia have not been
previously reported. These effects of intravenous amioda-
rone on sustained sinus node reentrant tachycardia are in
agreement with those previously reported (20,21) in AV
nodal reentrant tachycardia. The mechanism of the effect
of amiodarone on sinus node reentrant tachycardia is prob-
ably related to induction of block in sinus node pathways.
Previous studies in anesthetized dogs (22) demonstrated
slowing of sinus node discharge rate after intravenous amio-
darone after pretreatment with propranolol and atropine. In
rabbit sinus node preparations, amiodarone has been shown
to prolong action potential duration and reduce the slope of
diastolic depolarization (23). In addition, Castillo-Fenoy et
al. (24) suggested that amiodarone might induce sinoatrial
block.
Clinical implications. Our findings suggest that sus-
tained sinus node reentrant tachycardia I) is an important
clinical entity in the genesis of paroxysmal reentrant supra-
ventricular tachycardia; 2) is not as benign as previously
thought, since like other forms of supraventricular tachy-
cardia it can result in dizziness and syncope; 3) can mas-
querade as AV nodal reentrant tachycardia and atrial tachy-
cardia with AV block; 4) usually occurs in the presence of
organic heart disease; and 5) can be prevented by the in-
travenous administration of digitalis glycosides, verapamil
and amiodarone.
We acknowledge Nabil El-Sherif', MD for his encouragement and support,
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